Ardelyx Inc. Stock
Ardelyx, Inc. is a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medicines aimed at treating kidney and cardiovascular diseases. The company uses a unique approach to drug discovery, developing therapeutics that target ion channels and transporters, which play a critical role in regulating activities in the body. Ardelyx's lead product candidate, tenapanor, is being studied for the treatment of conditions such as hyperphosphatemia in patients with chronic kidney disease, irritable bowel syndrome with constipation, and diverticulosis. The company is listed on the NASDAQ exchange under the ticker symbol ARDX.
Pros and Cons of Ardelyx Inc. in the next few years
Performance of Ardelyx Inc. vs. its peers
|Hepion Pharmaceuticals Inc.||-2.420%||-9.743%||-14.700%||-37.288%||139.427%||-59.238%||-|
|Champions Oncology Inc||-1.050%||-13.364%||-10.048%||-50.850%||-8.738%||-20.675%||-|